Arif Awan

509 total citations
48 papers, 296 citations indexed

About

Arif Awan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Arif Awan has authored 48 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 14 papers in Cancer Research. Recurrent topics in Arif Awan's work include Bone health and treatments (11 papers), Cancer Treatment and Pharmacology (11 papers) and Advanced Breast Cancer Therapies (9 papers). Arif Awan is often cited by papers focused on Bone health and treatments (11 papers), Cancer Treatment and Pharmacology (11 papers) and Advanced Breast Cancer Therapies (9 papers). Arif Awan collaborates with scholars based in Canada, United Kingdom and United States. Arif Awan's co-authors include Khashayar Esfahani, Mark Clemons, Lisa Vandermeer, Brian Hutton, Carol Stober, Deanna Saunders, Dean Fergusson, Terry L. Ng, Gregory R. Pond and Sharon F. McGee and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Arif Awan

43 papers receiving 290 citations

Peers

Arif Awan
Sarah Yentz United States
Şener Cihan Türkiye
P. Zamora Spain
Robin Schaffar Switzerland
D. Greenberg United Kingdom
Arif Awan
Citations per year, relative to Arif Awan Arif Awan (= 1×) peers Smita Kayal

Countries citing papers authored by Arif Awan

Since Specialization
Citations

This map shows the geographic impact of Arif Awan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arif Awan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arif Awan more than expected).

Fields of papers citing papers by Arif Awan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arif Awan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arif Awan. The network helps show where Arif Awan may publish in the future.

Co-authorship network of co-authors of Arif Awan

This figure shows the co-authorship network connecting the top 25 collaborators of Arif Awan. A scholar is included among the top collaborators of Arif Awan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arif Awan. Arif Awan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
McGee, Sharon F., Mark Clemons, Gregory R. Pond, et al.. (2024). A Randomized Trial Comparing Concurrent versus Sequential Radiation and Endocrine Therapy in Early-Stage, Hormone-Responsive Breast Cancer. Current Oncology. 31(8). 4531–4545. 2 indexed citations
3.
Clemons, Mark, Lisa Vandermeer, Khaled El Emam, et al.. (2024). The REthinking Clinical Trials Program Retreat 2023: Creating Partnerships to Optimize Quality Cancer Care. Current Oncology. 31(3). 1376–1388.
4.
Perez, Cesar A., Jason T. Henry, Nehal J. Lakhani, et al.. (2023). 660MO First-in-human study of SGN-B7H4V, a B7-H4-directed vedotin ADC, in patients with advanced solid tumors: Preliminary results of a phase I study (SGNB7H4V-001). Annals of Oncology. 34. S464–S465. 9 indexed citations
6.
Stober, Carol, Arif Awan, Terry L. Ng, et al.. (2022). Symptomatic skeletal-related events in patients receiving longer term bone-modifying agents for bone metastases from breast and castration resistant prostate cancers. Supportive Care in Cancer. 30(5). 3977–3984. 9 indexed citations
7.
Dent, Susan, Dean Fergusson, Olexiy Aseyev, et al.. (2021). A Randomized Trial Comparing 3- versus 4-Monthly Cardiac Monitoring in Patients Receiving Trastuzumab-Based Chemotherapy for Early Breast Cancer. Current Oncology. 28(6). 5073–5083. 6 indexed citations
8.
9.
Mates, Mihaela, Philippe L. Bédard, John Hilton, et al.. (2021). 38MO IND.236: A Canadian Cancer Trial Group (CCTG) phase Ib trial of combined CFI-402257 and weekly paclitaxel (Px) in patients with HER2-negative (HER2-) advanced breast cancer (BC). Annals of Oncology. 32. S16–S16. 2 indexed citations
10.
11.
McGee, Sharon F., Carol Stober, Terry L. Ng, et al.. (2021). Adjuvant bisphosphonate use in patients with early stage breast cancer: Patient perspectives on treatment acceptability and potential de-escalation. Journal of bone oncology. 27. 100351–100351. 3 indexed citations
12.
McGee, Sharon F., Lisa Vandermeer, Gail Larocque, et al.. (2021). Adjuvant bisphosphonate use in patients with early stage breast cancer: a physician survey. Breast Cancer Research and Treatment. 187(2). 477–486. 7 indexed citations
13.
Clemons, Mark, Sharon F. McGee, Lisa Vandermeer, et al.. (2021). Perceptions around bone-modifying agent use in patients with bone metastases from breast and castration resistant prostate cancer: a patient survey. Supportive Care in Cancer. 29(11). 6903–6912. 6 indexed citations
15.
Ng, Terry L., Megan M. Tu, Mohammed Ibrahim, et al.. (2020). Long-term impact of bone-modifying agents for the treatment of bone metastases: a systematic review. Supportive Care in Cancer. 29(2). 925–943. 31 indexed citations
16.
Clemons, Mark, Carol Stober, Fiona MacDonald, et al.. (2020). A randomized trial comparing vascular access strategies for patients receiving chemotherapy with trastuzumab for early-stage breast cancer. Supportive Care in Cancer. 28(10). 4891–4899. 22 indexed citations
17.
Awan, Arif, Terry L. Ng, Henry Jacob Conter, et al.. (2020). Feasibility outcomes of a randomised, multicentre, pilot trial comparing standard 6-monthly dosing of adjuvant zoledronate with a single one-time dose in patients with early stage breast cancer. Journal of bone oncology. 26. 100343–100343. 5 indexed citations
18.
Awan, Arif, Andrew Robinson, Carol Stober, et al.. (2019). A prospective, multicentre, randomized trial comparing vascular access strategies for patients receiving non-trastuzumab containing chemotherapy for early stage breast cancer. Annals of Oncology. 30. iii66–iii67. 1 indexed citations
19.
Awan, Arif & Khashayar Esfahani. (2018). Endocrine Therapy for Breast Cancer in the Primary Care Setting. Current Oncology. 25(4). 285–291. 45 indexed citations
20.
Awan, Arif, et al.. (1996). Health advice for Asian women with diabetes.. PubMed. 11(12). 794–6. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026